Cannabis Testing Market: Overview
Cannabis is a flowering plant predominantly found is Africa, Asia, and the Americas. Cannabis is non-conventionally used as a hemp fiber, hemp oils, used for medicinal resolutions, and as a frivolous drug. Industrial hemp crops are produced from the cannabis plants, which produce a plenty of fiber. To gratify the UN Narcotics Convention, some of the cannabis strains are raised to produce nominal levels of tetrahydrocannabinol, the main psychoactive component. There are large number of plants, which are selectively raised to produce trahydrocannabinol, which is found by curing the flowers. Some of the other compounds, which include hashish and hash oil, are mined from the cannabis plant. These compounds are also used in testing procedure and thus, this would boost the cannabis testing market.
Click here to Download Sample report copy: https://www.coherentmarketinsights.com/insight/request-sample/170
Despite regulatory challenges, the future of cannabis testing market is promising
In August 2016, the Drug Enforcement Agency (DEA) left its decision of classifying cannabis as a Schedule 1, deeming it to be a dangerous narcotic. This decision, however, will lead to rise in number of registered cannabis manufacturers, which explains that additional green light in research on cannabis, a strong move which increases the call for laboratory services. A superficial search of the medical literature shows that there are over 4,000 articles on cannabis on pain management. One of the biggest drivers is adult frivolous use, which is legal in some of the states in US. Meanwhile, in 2016, cannabis for medicinal purpose has received major support, claiming 89% of Americans allegedly support legalization versus 74% in 2011 and approximately 25 states have legalized medical cannabis, while several more are on track to do so boosting the cannabis testing market globally.